FDA clears Nidek's OPD (Optical Path Difference)-Scan system:
This article was originally published in Clinica
Executive Summary
Nidek has received US FDA 510(k) marketing clearance for its stand-alone device for generating refractive eye maps. The OPD (Optical Path Difference)-Scan diagnostic system can create refractive power maps that show the total optical system aberrations within both eyes, claims the Fremont, California company. The product allows doctors to use one machine to create comprehensive, refractive power maps that are normally produced using at least two tests on two different machines, says Nidek's general manager and vice-president, Hiroshi Okada.